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Abstract
A rapid, simple and sensitive synchronous specrtofluorimetric method has been developed for the simultaneous
analysis of binary mixture of metoprolol (MTP) and felodipine (FDP). The method is based upon measurement of
the synchronous fluorescence intensity of the two drugs at Δl of 70 nm in aqueous solution. The different
experimental parameters affecting the synchronous fluorescence intensities of the two drugs were carefully studied
and optimized. The fluorescence intensity-concentration plots were rectilinear over the ranges of 0.5-10 μg/mL and
0.2-2 μg/mL for MTP and FDP, respectively. The limits of detection were 0.11 and 0.02 μg/mL and quantification
limits were 0.32 and 0.06 μg/mL for MTP and FDP, respectively. The proposed method was successfully applied for
the determination of the two compounds in their commercial tablets and the results obtained were favorably
compared to those obtained with a comparison method.
Introduction
Felodipine (FDP), Ethyl methyl 4-(2, 3-dichlorophenyl)-
1, 4-dihydro-2, 6-dimethylpyridine-3, 5-dicarboxylate
(Figure 1a) is a dihydropyridine calcium-channel
blocker. It is used in the management of hypertension
and angina pectoris [1]. Metoprolol (MTP), (±)-1-Iso-
propylamino-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol
(Figure 1b), is a cardio-selective b blocker. It has been
reported that MTP lacks intrinsic sympathomimetic
activity and has little or no membrane-stabilizing activ-
ity. It is mainly used in the treatment of hypertension,
angina pectoris, cardiac arrhythmias, myocardial infarc-
tion, and heart failure. It is also used in the management
of hyperthyroidism and in the prophylactic treatment of
migraine [1].
Both drugs are official in the United States Pharmaco-
poeia (USP, 2). The USP [2] recommended HPLC meth-
ods for the determination of each of FDP and MTP in
pure form and in different dosage forms. Since the com-
bined therapy of FDP and MTP has been clinically
proven to be significantly efficient in the treatment of
hypertension, it became important to develop and vali-
date a reliable method for the separation and determina-
tion of the two drugs in their commercially available
formulations. Only few methods have been reported in
the literature for the assay of such mixture, using che-
mometric assisted spectrophotometric methods [3,4]
and HPLC methods [3-5].
Only one spectrofluorimetric method has been devel-
oped for the analysis of MTP in human plasma using
trilinear decomposition-based techniques [6]. Regarding
FDP, a convential fluorimetric method was reported for
its determination in presence of ramipril in their com-
bined tablets Triacor
® [7].
To the best of our knowledge, neither conventional
nor synchronous spectrofluorimetry has been reported
for the analysis of MTP and FDP in their binary
mixtures.
The normal excitation fluorescence spectra of MTP
and FDP are greatly overlapped. This observation led us
to utilize synchronous fluorescence spectroscopy (SFS)
to solve such problem by measuring Synchronous
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MTP and FDP respectively.
Based on chemical features of both drugs, and high
therapeutic effect of MTP and FDP combined in treat-
ment of hypertension, the (SFS) technique was devel-
oped for the simultaneous determination of both drugs
in their combined tablets.
Synchronous fluorescence spectroscopy (SFS) has sev-
eral advantages over conventional fluorescence spectro-
scopy, including simple spectra, high selectivity and low
interference [8]. Because of its sharp, narrow spectrum,
SFS serves as a very simple, effective method for achiev-
ing data for quantitative determination in a single run [9].
Experimental
Material
￿ Metoprolol tartrate pure sample was kindly pro-
vided by Sigma company.
￿ Felodipine pure sample was kindly provided by
Minapharm.
￿ Logimax
® tablets labeled to contain 50 mg of MTP
and 5 mg of FDP (Batch # 90015) were obtained
from commercial source in the local market.
Reagents
All reagents and solvents used were of Analytical
Reagent Grade.
￿ Methanol (Merck, Darmstadt, Germany).
￿ Acetic acid, Sodium acetate and Boric acid (BDH,
UK).
￿ Acetate buffer 0.2 M (pH 4.5) was prepared by
mixing appropriate volume of 0.2 M acetic acid with
0.2 M sodium acetate. Borate buffers (pH 8.5) were
prepared by mixing appropriate volumes of 0.02 M
boric acid with 0.2 M sodium hydroxide.
￿ Sodium hydroxide ((BDH, UK), 0.1 M aqueous
solution was freshly prepared.
Apparatus
Fluorescence spectra and measurements were recorded
using a Perkin-Elmer UK model LS 45 luminescence
spectrometer, equipped with a 150 Watt Xenon arc
lamp, gratting excitation and emission monochromators
for all measurements and a Perkin-Elmer recorder. Slit
widths for both monochromators were set at 10 nm. A
1 cm quartz cell was used. The SF spectra were esti-
mated at 260 nm and 375 nm for MTP and FDP,
respectively.
A Consort NV P901 digital pH Meter (Belgium) cali-
brated with standard buffers was used for checking the
pH of the buffer solutions used.
Standard Solutions
Stock solutions of MTP and FDP were prepared by dis-
solving 10.0 mg of the studied compounds in 100 mL of
methanol in a calibrated flask and were further diluted
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Figure 1 Structural formulae of the studied drugs. Where: (a) Felodipine (FDP), (b) Metoprolol (MTP).
Table 1 Performance data of the determination of MTP
and FLD in pure form by the proposed method
Parameter Metoprolol Felodipine
Concentration range (μg/mL) 0.5-10.0 0.2-2.0
Correlation coefficient 0.9999 0.9999
Slope 56.36 164.51
Intercept 11.12 7.15
Limit of detection (LOD) (μg/mL) 0.11 0.02
Limit of Quantification (LOQ) (μg/mL) 0.32 0.06
Sy/x 2.87 1.31
Sa 1.82 0.91
Sb 0.33 0.91
%RSD 1.49 1.17
%Er 0.61 0.48
Sy/x, Standard deviation of the residuals;
Sa, Standard deviation of the intercept
% RSD = Relative standard deviation;
Sb, Standard deviation of the slope
% Error = %RSD/√n.
n=6 .
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μg/mL of each drug. FDP standard solution was pro-
tected from light due to its photosensitivity. The stan-
dard solutions were stable for 10 days when kept in the
refrigerator.
Recommended procedures
Calibration Curves
Aliquots of MTP and FDP standard solutions covering
the working concentration range cited in table 1 were
transferred into a series of 10 mL volumetric flasks.
Then the solutions were diluted to volume with distilled
water and mixed well. Synchronous fluorescence spectra
of the solutions were recorded by scanning both mono-
chromators at a constant wavelength difference Δl =7 0
nm and scan rate of 600 nm/min using 10 nm excita-
tion and emission windows. The intensities of the SF
spectra were estimated at 260 nm and 375 nm for MTP
and FDP, respectively. A blank experiment was per-
formed simultaneously. The relative fluorescence inten-
sity of the synchronous spectra was plotted vs.t h ef i n a l
concentration of the drugs (μg/mL) to get the calibra-
tion Curves. Alternatively, the corresponding regression
equations were derived.
Procedure for the synthetic mixture
Aliquots of MTP and FDP standard solutions in the
ratio of 10:1 were transferred into a series of 10 mL
volumetric flasks. Then the solution was diluted to the
volume with distilled water, and mixed well. The recom-
mended procedure under Calibration Curve was then
performed. The relative SF intensities were measured
and the corresponding concentrations were derived
from the calibration curves or the corresponding regres-
sion equations.
Procedure for commercial tablets
The films of ten coated (individually weighed) tablets
were gently removed with water. The tablets were then
dried, weighed, powdered and mixed well. A weighed
quantity of the powder equivalent to 10.0 mg MTP
and 1 mg of FDP (in their ratio of 10:1) was trans-
ferred into a small conical flask and extracted with 50
mL of methanol by ultrasonication for 30 min. The
extract was filtered with acrodisc GHP (Gelman
Hydrophilic Polypropy lene membrane) into a 100 mL
volumetric flask. The conical flask was washed with
few mLs of methanol. The washings were passed into
the same volumetric flask and completed to the mark
w i t ht h es a m es o l v e n t .
Aliquots covering the working concentration range
were transferred into 10 mL volumetric flasks. The
recommended procedure under “Calibration Curve” was
performed. The nominal content of the Tablets were
determined either from a previously plotted calibration
curve or using the corresponding regression equation.
Results and discussion
Synchronous fluorescence spectra of MTP and FDP
Metoptolol was found to exhibit two excitation wave-
lengths at 225 and 275 nm, and two emission spectra at
306 and 460 nm (Figure 2). felodipine was found to
exhibit maximum fluorescence intensity at 440 nm after
excitation at 225, 240 and 375 nm (Figure 2). The emis-
sion spectra of both MTP and FDP greatly overlapped
(Figure 3). This fact hindered the use of direct measure-
ment for the simultaneous determination of MTP and
FDP. This problem is more aggravated if it is desired to
determine these compounds in their co-formulated
preparations
It was necessary to record first the normal synchro-
nous spectra for both MTP and FDP. There is no over-
lap between them after subtracting the value of the
blank. Figure 4 shows the SF spectra of different con-
centrations of MTP at 260 nm in presence of constant
concentration of FDP (1.0 μg/mL) and the blank syn-
chronous spectra, whereas, Figure 5 illustrates the SF
spectra of different concentrations of FDP at 375 nm in
presence of constant concentration of MTP (10.0 μg/
mL) and the blank synchronous spectra.
Optimization of experimental conditions
Different experimental parameters affecting the perfor-
mance of the proposed method were carefully studied
and optimized. Such factors were changed individually
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Figure 2 Fluorescence spectra of: (A, A’,A ’’)s p e c t r ao fM T P
(0.5 μg/mL) in distilled water. (B, B’) spectra of FDP (2 μg/mL) in
distilled water. Where: (A, B) are excitation spectra, (A’,A ’’,B ’) are
emission spectra.
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Page 3 of 9while others were kept constant. These factors included:
Δl, l max, pH and type of the diluting solvent.
Selection of optimum Δl
The optimum Δl value is an essential factor for per-
forming the synchronous fluorescence scanning
technique with regards to its resolution, sensitivity and
features. It can directly influence spectral shape, band
width and signal value. For this reason a wide range of
Δl (20, 40, 60, 70, 80, 100 and 120 nm) was examined
(Figure 6). For MTP, when Δl was higher than 70 nm,
the fluorescence intensity was less sensitive while if Δl
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Figure 3 Emission fluorescence spectra of MTP and FDP. a: (A, B) spectra of MTP and FDP, respectively, after excitation at 225. b: (C, D)
spectra of MTP and FDP, respectively, after excitation at 375.
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Page 4 of 9was less than 70 nm the fluorescence intensity was very
high and didn’t enabled the simultaneous determination
of the studied drugs in their pharmaceutical ratio (10
MTP: 1 FDP). For FDP, when Δl w a sl e s st h a n7 0n m ,
the fluorescence intensity was less sensitive while if Δl
was 70 nm or higher it gave nearly the same sensitivity.
Therefore, Δl of 70 nm was chosen as optimal one for
separation of MTP and FDP mixtures, since it elimi-
nated the spectral interference caused by each com-
pound in the mixture and gave the desired sensitivity.
Selection of appropriate l max
Metoprolol SF spectra using Δl of 70 have two values of
l max, one at 233 and the other at 260 nm. The one at
260 nm didn’t afford the higher sensitivity, yet it was
used because it enabled the determination of FDP &
MTP simultaneously at the ratio of 1:10.
Selection of optimum pH
The influence of pH on the fluorescence intensity of the
two drugs was studied using different buffers covering
the whole pH range, e.g. acetate buffer (pH 3.6-5.6) and
borate buffer pH (6-9.5). It was found that, using any of
these two buffers either does not affect the synchronous
fluorescence intensity or even decrease it. Therefore, for
simplicity of the method no buffer was used throughout
the study.
Effect of diluting solvent
Dilution with different solvents including; water, metha-
nol, acetone, acetic acid, acetonitrile, dimethyl sulfoxide
(DMSO), and dimethyl formamide (DMF) was employed
(Figure 7). Water only gave the highest relative synchro-
nous fluorescence intensity for MTP and FDP compared
with the other solvents. Thus, water was chosen as the
diluting solvent throughout the study.
Validation of the Method
The validity of the method was tested regarding; linear-
ity & range, accuracy, repeatability, precision and speci-
ficity according to ICH Q2B recommendations [10].
Linearity and Range
The regression plots showed a linear dependence of
RSFI values on drug concentration over the range cited
in Table 1.
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Figure 4 Synchronous fluorescence spectra of.( 1 )F D P( 1μg/
mL). (2) a-f, MTP (0.5, 1, 2, 4, 8 and 10 μg/mL). (3) blank
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Figure 5 Synchronous fluorescence spectra of: (1) MTP (10 μg/
mL). (2) a-f, FDP (0.2, 0.4, 0.5, 0.8, 1 and 10 μg/mL). (3) blank
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Figure 6 Synchronous fluorescence spectra of MTP and FDP at
different Δl. Where: (A, B and C) for MTP at Δl of 60, 70 and 80
nm, respectively. (A’,B ’ and C’) for FDP at Δl of 60, 70 and 80 nm,
respectively.
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evaluation of the regression lines, using the standard
deviation of the residuals (Sy/x), the standard deviation
of the intercept (Sa) and standard deviation of the slope
(Sb). The results are abridged in Table 1. The small
values of the figures point out to the low scattering of
the points around the calibration curves and high
precision.
Limit of quantification (LOQ) and limit of detection (LOD)
The limit of quantification (LOQ) was determined by
establishing the lowest concentration that can be mea-
sured according to ICH Q2B recommendations [10],
below which the calibration graph is non linear. The
limit of detection (LOD) was determined by evaluating
the lowest concentration of the analyte that can be read-
ily detected. The results of LOD and LOQ of MTP and
FDP by SDSFS method are abridged in Table 1.
LOQ and LOD were calculated according to ICH Q2B
recommendations [10]:
LOQ = 10 s/S
LOD = 3.3 s/S
Where: S is the slope and s is the standard deviation
of the intercept of regression line of the calibration
curve.
Accuracy and precision
The proposed methods were applied to the determina-
tion of authentic samples of MTP and FDP over the
concentration ranges cited in Table 2 in order to evalu-
ate their accuracy. The results obtained were in good
agreement with those obtained using comparison
method [4]. Using the Student’s t-test and the variance
ratio F-test, [11] revealed no significant difference
between the performance of the two methods regarding
the accuracy and precision, respectively (Table 2).
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Figure 7 Effect of diluting solvent on relative synchronous
fluorescence intensity for MTP and FDP.
Table 2 Application of the synchronous fluorimetry to the determination of the studied drugs in the pure form
Parameters Concentration taken (μg/mL) Concentration found (μg/mL) % Found Comparison method (4)
1-MTP 0.5 0.509 101.80 98.73
1.0 1.015 101.5 101.84
2.0 2.009 100.45 99.28
4.0 3.927 98.18
8.0 8.051 100.64
10.0 9.984 99.84
X 100.40 99.95
SD ± 1.3 ± 1.66
t-test 0.45 (2.36)
F value 1.63 (5.79)
2-FDP 0.2 0.202 101.12 101.33
0.4 0.395 98.69 98.24
0.5 0.492 98.43 100.66
0.8 0.807 100.89
1.0 1.008 100.78
2.0 1.996 99.80
X 99.95 100.08
SD ± 1.17 ± 1.63
t-test 0.13 (2.36)
F value 1.3 (5.79)
Figures between parenthesis are the tabulated t (at degree of freedom = 7 for both drugs) and F values (at degree of freedom = 2, 5 for both drugs),
respectively at p = 0.05 [11].
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Page 6 of 9T h ep r o p o s e dm e t h o dw a sa p p l i e dt ot h es i m u l t a -
neous determination of MTP with FDP in synthetic
mixtures containing different concentrations of both
drugs in a ratio of 10:1 (Figure 8). The relative synchro-
nous fluorescence intensities were measured for both
drugs. The RSFI of MTP was measured at 260 nm
where FDP shows nil contribution, similarly, the RFSI
for FDP was measured at 375 nm where MTP shows nil
contribution. The concentrations of both drugs in the
synthetic mixture were calculated according to the linear
regression equation of the calibration graphs. The
results indicate high accuracy of the proposed method
as shown in Table 3.
The method was assessed regarding precision by eval-
uating repeatability and intermediate precision.
￿ Repeatability: The repeatability was performed by
applying the proposed methods for the determina-
tion of three concentrations of MTP and FDP in
pure forms on three successive times, and the results
are listed in Table 4.
￿ Intermediate precision: Intermediate precision was
evaluated through repeated analysis of MTP and
FDP in pure form applying the proposed method,
using the concentrations showed in Table 4 for a
period of 3 successive days.
Selectivity
The proposed SFS method allowed the selective deter-
mination of each drug in presence of the other without
any interference proving its selectivity and ability to
resolve a mixture of the two drugs.
The proposed method was found to be specific for the
two studied drugs in their combined tablets without
interference from common tablet excipients such as
Titanium oxide, Iron oxide, anhydrous lactose, propyl
gallate, colloidal silicon dioxide, paraffin, hypromellose,
cellulose, hydroxyl propyl cellulose sodium aluminum
silicate, macrogel, sodium stearyl fumarate and poloxyl
40-hydrogenated caster oil. These matrix components
did not interfere with the proposed method.
Pharmaceutical Applications
The proposed method was applied to the determination
of the studied drugs in their coformulated tablet Logi-
max
®. It is a film coated slow release enteric tablet. As
most of the analytes and tablet excipients were insoluble
in water and soluble in methanol, a solution containing
methanol was necessary to dilute drugs and insure for
tablet disintegration [4]. Acrodisc GHP was used to
ultra clean the extract of particles 0.45 μm or larger [4].
The specificity of the method was investigated by obser-
ving no interference encountered from the common
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Figure 8 synchronous fluorescence spectra of. a, MTP (8 μg/mL);
b, FDP (0.8 μg/mL); c, synthetic mixture of MTP (8 μg/mL) and FDP
(0.8 μg/mL).
Table 3 Application of the proposed method for determination of the studied drugs in their synthetic mixtures.
Sample Concentration taken (μg/mL) Concentration found(μg/mL) Recovery %
MTP FDP MTP FDP MTP FDP
MTP and FDP mixture 5.0 0.5 4.987 0.494 99.73 98.72
8.0 0.8 7.942 0.796 99.27 99.56
10.0 1.0 9.931 0.982 99.31 98.2
X 99.44 98.83
±S D ± 0.255 ± 0.686
% RSD 0.256 0.694
% Error 0.148 0.401
Each result is the average of three separate determinations.
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obtained during determination of MTP and FDP in
Logimax
® tablets (Table 5).
Conclusion
A new simple and sensitive method was explored for the
simultaneous determination of MTP and FDP in binary
mixture. The synchronous spectrofluorometric method,
by virtue of its high sensitivity, could be applied to the
analysis of both drugs in their co-formulated dosage
forms. It was possible to measure low concentrations as
0.32 and 0.06 μg/mL for MTP and FDP respectively
with good accuracy. Moreover, synchronous spectro-
fluorimetric technique enables the determination of
MTP in the presence of FDP and vice versa. Moreover,
the proposed method is time saving.
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